Slides
Page 2
at www.bbbiotech.com .
Page 4
4
Page 5
5 Top 10 performing portfolio holdings in 2025
Page 6
6
Page 7
7
Page 8
8
Page 9
9
Page 10
10
Page 11
2026 driven by catalyst - rich execution Selected k ey milestones 2026 11
Page 12
12
Page 15
Bellevue Asset Management AG Theaterstrasse 12 CH-8001 Zürich Tel. +41 44 267 67 00 E-Mail: info@bellevue.ch www.bbbiotech.com Investor Relations: ir@bbbiotech.com Rachael Burri Head Investor Relations, rbu@bellevue.ch